Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Neurosurgical oncology

State-of-the-art imaging for glioma surgery.

Niels Verburg; Philip C de Witt Hamer

Originally published in Neurosurgical review · 2020-06-30

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Diffuse gliomas are infiltrative primary brain tumors with a poor prognosis despite multimodal treatment. Maximum safe resection is recommended whenever feasible. The extent of resection (EOR) is positively correlated with survival. Identification of glioma tissue during surgery is difficult due to its diffuse nature. Therefore, glioma resection is imaging-guided, making the choice for imaging technique an important aspect of glioma surgery. The current standard for resection guidance in non-enhancing gliomas is T2 weighted or T2w-fluid attenuation inversion recovery magnetic resonance imaging (MRI), and in enhancing gliomas T1-weighted MRI with a gadolinium-based contrast agent. Other MRI sequences, like magnetic resonance spectroscopy, imaging modalities, such as positron emission tomography, as well as intraoperative imaging techniques, including the use of fluorescence, are also available for the guidance of glioma resection. The neurosurgeon's goal is to find the balance between maximizing the EOR and preserving brain functions since surgery-induced neurological deficits result in lower quality of life and shortened survival.

Discussion

How can imaging aid glioma surgery? We know gliomas are widespread in the brain by the time of diagnosis, so a curative resection is not possible [14]. Still, there is accumulating evidence that removing more of the tumor improves PFS and OS [8, 86]. Since glioma is an infiltrative disease, macroscopic recognition of the tumor within the normal brain can be very difficult. Imaging has the possibility to visualize the tumor and thus overcoming the macroscopic problems. Ideally, an imaging modality would not miss any tumor, 100% sensitivity, and only show tumor, 100% specificity.

Editorial reading guide

  • How were patients or cases selected, and what did the authors use as a comparator?
  • Which outcomes, complications and follow-up intervals determine how far the findings apply?